Verona Pharma plc Quarterly Revenues in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Verona Pharma plc quarterly/annual Revenues history and growth rate from Q3 2020 to Q3 2024.
  • Verona Pharma plc Revenues for the quarter ending September 30, 2024 was $5.62M.
  • Verona Pharma plc annual Revenues for 2023 was $0.000, a 100% decline from 2022.
  • Verona Pharma plc annual Revenues for 2022 was $458K, a 98.9% decline from 2021.
  • Verona Pharma plc annual Revenues for 2021 was $40M.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.62M +$5.62M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q3 2022 $0 -$40M -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q3 2021 $40M +$40M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.